Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to study the effectiveness and complications of novel immunotherapies used in the treatment of multiple myeloma in routine care in Norway. The aim is to close k...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
St. Olavs Hospital
Collaborators
NCT05451771 · AL Amyloidosis
NCT07609576 · Lymphoma Neoplasms, Myeloma Multiple, and more
NCT06383143 · AL Amyloidosis, Smoldering Multiple Myeloma, and more
NCT07523555 · Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL, and more
NCT06192979 · Amyloidosis; Systemic, AL Amyloidosis
Sørlandet Hospital - Arendal
Arendal
Ålesund hospital, Department of hematology
Ålesund
Haukeland University Hospital
Bergen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions